| Literature DB >> 23671347 |
Paul R Lee1, Gerald V Raymond.
Abstract
Zellweger syndrome (ZS) is a severe manifestation of disease within the spectrum of peroxisome biogenesis disorders that includes neonatal adrenoleukodystrophy, infantile Refsum disease, and rhizomelic chondroplasia punctata. Patients with ZS present in the neonatal period with a characteristic phenotype of distinctive facial stigmata, pronounced hypotonia, poor feeding, hepatic dysfunction, and often seizures and boney abnormalities. In patients with ZS, a mutation in one of the PEX genes coding for a peroxin (a peroxisome assembly protein) creates functionally incompetent organelles causing an accumulation of very long chain fatty acids (VLCFA), among other complications. Despite an absence of treatment options, prompt diagnosis of ZS is important for providing appropriate symptomatic care, definitive genetic testing, and counseling regarding family planning.Entities:
Mesh:
Year: 2013 PMID: 23671347 PMCID: PMC3908348 DOI: 10.1212/WNL.0b013e3182929f8e
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910